ArticleSchizophrenia (Heidelberg, Germany)2025
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.
Abstract read
In one paragraph
Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Treatment Choices for Youth at Clinical High-Risk of Psychosis: Methods of an Open Trial.Early intervention in psychiatry · 2025Trial
- Association Between Social and Role Functioning and Transition to Psychosis in the North American Prodrome Longitudinal Study Consortium.Schizophrenia bulletin · 2026Article
- Processing Speed and Verbal Learning Ability as Predictors of Assessor-Rated and Ecological Momentary Assessment Self-Reported Functioning: Findings from AMP SCZ.Schizophrenia bulletin · 2026Article
- Insomnia Symptoms and Psychopathology in Individuals at Clinical High Risk for Psychosis.Early intervention in psychiatry · 2026Article
- Relationship among Sleep Disturbance, Stress, and Suicidal Ideation in Clinical High Risk for Psychosis.Schizophrenia bulletin open · 2026Article
- Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative.Schizophrenia (Heidelberg, Germany) · 2025Article
- Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program.Schizophrenia (Heidelberg, Germany) · 2025Article
- Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.Schizophrenia (Heidelberg, Germany) · 2025Article
- Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program.Schizophrenia (Heidelberg, Germany) · 2025Article
- The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.Schizophrenia (Heidelberg, Germany) · 2025Article
- Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program.Schizophrenia bulletin open · 2025Article
- Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program.Schizophrenia bulletin open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
80 authors.
Jean AddingtonDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. jmadding@ucalgary.ca.ORCID http://orcid.org/0000-0002-8298-0756
Lu LiuDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Amy BraunDepartment of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Andrea AutherDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY, USA.
Monica E CalkinsDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Barbara A CornblattDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY, USA.
Cheryl M CorcoranDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-8902-4353
Paolo Fusar-PoliDepartment of Psychosis Studies, King's College, London, UK.
Melissa J KerrOrygen, Parkville, VIC, Australia.
Catalina V Mourgues-CodernDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Angela R NunezDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Dominic OliverDepartment of Psychosis Studies, King's College, London, UK.ORCID http://orcid.org/0000-0002-8920-3407
Gregory P StraussDepartment of Psychology, University of Georgia, Athens, GA, USA.
Barbara C WalshDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Luis K AlamedaDepartment of Psychosis Studies, King's College, London, UK.ORCID http://orcid.org/0000-0002-8621-2885
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID http://orcid.org/0000-0003-3382-4754
Nicholas J K BreitbordeDepartment of Psychiatry and Behavioral Health, Ohio State University, Columbus, OH, USA.
Matthew R BroomeInstitute for Mental Health, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0002-6963-8884
Kristin S CadenheadUniversity of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-5952-4605
Ricardo E CarrionDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY, USA.ORCID http://orcid.org/0000-0002-6393-392X
Eric Yu Hai ChenNanyang Technological University, LKC School of Medicine, Nanyang, Singapore.ORCID http://orcid.org/0000-0002-5247-3593
Jimmy ChoiOlin Neuropsychiatry Research Center, Hartford HealthCare Behavioral Health Network, Hartford, CT, USA.
Michael J ColemanDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Philippe ConusService de Psychiatrie Générale Dép. de Psychiatrie CHUV Lausanne, Lausanne, Switzerland.
Covadonga M Diaz-CanejaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID http://orcid.org/0000-0001-8538-3175
Dominic DwyerOrygen, Parkville, VIC, Australia.ORCID http://orcid.org/0000-0003-3949-5867
Lauren M EllmanDepartment of Psychology & Neuroscience, Temple University, Philadelphia, PA, USA.
Masoomeh FaghankhaniDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-0734-5047
Pablo A GasparDepartment of Psychiatry, IMHAY, University of Chile, Santiago, Chile.ORCID http://orcid.org/0000-0002-9682-5327
Carla GerberPrevention Science Institute, University of Oregon, Eugene, OR, USA.
Louise Birkedal GlenthøjCopenhagen Research Centre for Mental Health, Mental Health Copenhagen, Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
Leslie E HortonDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Christy HuiDepartment of Psychiatry, University of Hong Kong, Hong Kong, China.
Grace R JacobsDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9961-6507
Joseph KambeitzUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-8988-3959
Lana Kambeitz-IlankovicUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Matcheri S KeshavanBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Sung-Wan KimDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.ORCID http://orcid.org/0000-0002-6739-2163
Nikolaos KoutsoulerisDepartment of Psychosis Studies, King's College, London, UK.ORCID http://orcid.org/0000-0001-6825-6262
Jun Soo KwonDepartment of Psychiatry, Seoul National University College of Medicine, Seoul, South Korea.ORCID http://orcid.org/0000-0002-1060-1462
Kerstin LangbeinDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
Kathryn E LewandowskiDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1477-6187
Daniel MamahDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Patricia J MarcyDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY, USA.
Daniel H MathalonDepartment of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Vijay A MittalDepartment of Psychology, Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-9017-5119
Merete NordentoftMental Health Services in the Capital Region, Copenhagen, Denmark.
Godfrey D PearlsonDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Nora PenzelDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1624-386X
Jesus PerezCAMEO, Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Diana O PerkinsDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-9396-2206
Albert R PowersDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3057-5043
Jack RogersInstitute for Mental Health, University of Birmingham, Birmingham, UK.
Fred W SabbDepartment of Psychiatry, IMHAY, University of Chile, Santiago, Chile.
Jason SchiffmanDepartment of Psychological Science, University of California, Irvine, CA, USA.
Jai L ShahPEPP-Montreal, Douglas Research Centre, Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-7549-6990
Steven M SilversteinDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.ORCID http://orcid.org/0000-0002-0699-0960
Stefan SmesnyDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
William S StoneBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Andrew ThompsonOrygen, Parkville, VIC, Australia.
Judy L ThompsonDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
Rachel UpthegroveEarly Intervention for Psychosis Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.ORCID http://orcid.org/0000-0001-8204-5103
Swapna VermaInstitute of Mental Health, Singapore, Singapore.
Jijun WangShanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID http://orcid.org/0000-0001-5427-7425
Heather M WastlerDepartment of Psychiatry and Behavioral Health, Ohio State University, Columbus, OH, USA.
Alana WickhamDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Inge Winter-van RossumDepartment of Psychosis Studies, King's College, London, UK.
Daniel H WolfDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-9731-8781
Sylvain BouixDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1326-6054
Ofer PasternakDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Rene S KahnDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-5909-8004
Carrie E BeardenDepartments of Psychiatry and Biobehavioral Sciences & Psychology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8516-923X
John M KaneDepartment of Psychiatry, Donald and Barbara Zucker School of Medicine, Hempstead, NY, USA.
Patrick D McGorryOrygen, Parkville, VIC, Australia.
Kate BuccilliOrygen, Parkville, VIC, Australia.
Barnaby NelsonOrygen, Parkville, VIC, Australia.
Martha E ShentonDepartment of Psychiatry, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4235-7879
Scott W WoodsDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3103-5228
Accelerating Medicines Partnership® -Schizophrenia
Alison R YungInstitute of Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, VIC, Australia.ORCID http://orcid.org/0000-0002-0401-9791
Funding
ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2MNIMH NIH HHS U01 MH124639U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH124639
Abstract
Clinical ascertainment and clinical outcome are key features of any large multisite study. In the ProNET and PRESCIENT research networks, the Accelerating Medicines Partnership
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.